Diabetes, Obesity and Metabolism is a monthly peer-reviewed medical journal established in 1999 covering research on diabetes, obesity, and metabolism. The journal has a 2023 Clarivate impact factor of 5.4. From Wikipedia
New findings identify treatment duration, semaglutide use, non-diabetic status, metabolic rate, body composition, serum creatinine as predictors of weight-loss outcomes
